128 related articles for article (PubMed ID: 28224327)
1. Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG.
Erdağ E; Şahin C; Küçükali Cİ; Bireller S; Küçükerden M; Kürtüncü M; Türkoğlu R; Cakmakoglu B; Tüzün E; Arıcıoğlu F
Neurol Sci; 2017 May; 38(5):833-843. PubMed ID: 28224327
[TBL] [Abstract][Full Text] [Related]
2. Impact of Neuro-Behçet Disease Immunoglobulin G on Neuronal Apoptosis.
Giriş M; Bireller S; Küçükali Cİ; Hanağasi H; Değirmencioğlu S; Tüzün E
Noro Psikiyatr Ars; 2017 Mar; 54(1):67-71. PubMed ID: 28566962
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behçet's disease.
Vural B; Sehitoğlu E; Cavuş F; Yalçınkaya N; Haytural H; Küçükerden M; Ulusoy C; Uğurel E; Turan S; Bulut L; Türkoğlu R; Shugaiv E; Kürtüncü M; Atakan S; Güre AO; Gül A; Eraksoy M; Akman-Demir G; Tüzün E
J Neuroimmunol; 2013 Oct; 263(1-2):139-44. PubMed ID: 24035008
[TBL] [Abstract][Full Text] [Related]
4. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
Levinsky RJ; Lehner T
Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
[TBL] [Abstract][Full Text] [Related]
5. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease.
Vural B; Uğurel E; Tüzün E; Kürtüncü M; Zuliani L; Cavuş F; Içöz S; Erdağ E; Gül A; Güre AO; Vincent A; Ozbek U; Eraksoy M; Akman-Demir G
J Neuroimmunol; 2011 Oct; 239(1-2):91-7. PubMed ID: 21875754
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease.
Onen F; Tuncer D; Akar S; Birlik M; Akkoc N
Rheumatol Int; 2003 Nov; 23(6):289-93. PubMed ID: 12682785
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to mycobacterial heat shock protein (hsp)65 in the cerebrospinal fluid of neuro-Behçet patients.
Taşçi B; Direskeneli H; Serdaroglu P; Akman-Demir G; Eraksoy M; Saruhan-Direskeneli G
Clin Exp Immunol; 1998 Jul; 113(1):100-4. PubMed ID: 9697991
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
[TBL] [Abstract][Full Text] [Related]
9. Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases.
Celet B; Akman-Demir G; Serdaroğlu P; Yentür SP; Taşci B; van Noort JM; Eraksoy M; Saruhan-Direskeneli G
J Neurol; 2000 Dec; 247(12):935-9. PubMed ID: 11200685
[TBL] [Abstract][Full Text] [Related]
10. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.
Hamzaoui K; Borhani Haghighi A; Ghorbel IB; Houman H
J Neuroimmunol; 2011 Apr; 233(1-2):249-53. PubMed ID: 21367463
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of neurological manifestations of Behçet's disease: a retrospective monocentric study in Tunisia.
Houman MH; Bellakhal S; Ben Salem T; Hamzaoui A; Braham A; Lamloum M; Monia SK; Ben Ghorbel I
Clin Neurol Neurosurg; 2013 Oct; 115(10):2015-8. PubMed ID: 23830180
[TBL] [Abstract][Full Text] [Related]
12. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
[TBL] [Abstract][Full Text] [Related]
13. Myelin basic protein and index for neuro-Behçet's disease.
Zhan H; Cheng L; Wang X; Jin H; Liu Y; Li H; Liu D; Zhang X; Zheng W; Hao H; Li Y
Clin Immunol; 2023 May; 250():109286. PubMed ID: 36907539
[TBL] [Abstract][Full Text] [Related]
14. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
[TBL] [Abstract][Full Text] [Related]
15. Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.
Belghith M; Maghrebi O; Cherif A; Bahrini K; Saied Z; Belal S; Sassi SB; Barbouche MR; Kchaou M
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956031
[TBL] [Abstract][Full Text] [Related]
16. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
[TBL] [Abstract][Full Text] [Related]
17. Nutritional Status in patients with Neuro-Behçet's disease.
Erdoğan S; Sorgun MH; Kuzu Mumcu M; Kural MA; Rzayev S; Yücesan C
Turk J Med Sci; 2021 Aug; 51(4):1682-1688. PubMed ID: 33600096
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet's disease.
Saruhan-Direskeneli G; Yentür SP; Mutlu M; Shugaiv E; Yesilot N; Kürtüncü M; Akman-Demir G
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):25-7. PubMed ID: 23558092
[TBL] [Abstract][Full Text] [Related]
19. Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behçet's Disease.
Ugurel E; Erdag E; Kucukali CI; Olcay A; Sanli E; Akbayir E; Kurtuncu M; Gunduz T; Yilmaz V; Tuzun E; Vural B
In Vivo; 2019; 33(5):1493-1497. PubMed ID: 31471397
[TBL] [Abstract][Full Text] [Related]
20. Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.
Ben Dhifallah I; Borhani-Haghighi A; Hamzaoui A; Hamzaoui K
Iran J Immunol; 2019 Dec; 16(4):299-310. PubMed ID: 31885007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
